INS and gestational diabetes: Our findings were consistent with previous studies (12, 14, 17) and this risk factors profile identifies a phenotype which is already available at the diagnosis of GDM, allowing to adequately counsel the patient on the increased risk of need for insulin treatment to control glucose, if NT would not be sufficient.